Junqi Niu, Ph.D./M.D

Affiliations: 
Department of hepatology Jilin University First Hospital 
Google:
"Junqi Niu"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gao Y, Kong F, Song X, et al. (2021) Pradefovir Treatment in Patients with Chronic Hepatitis B: Week 24 Results from a Multicenter, Double-blind, Randomized, Noninferiority, Phase 2 Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Peng G, Wang Y, Ge P, et al. (2021) The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. Journal of Experimental & Clinical Cancer Research : Cr. 40: 278
Wei L, Zhao T, Zhang J, et al. (2021) Efficacy and Safety of a Nanoparticle Therapeutic Vaccine in Patients with Chronic Hepatitis B: A Randomized Clinical Trial. Hepatology (Baltimore, Md.)
Zhang Z, Guo H, Wang J, et al. (2021) Inhibition of the Neddylation Pathway Suppresses Enterovirus Replication. Virologica Sinica
Li X, Hollingshead N, Lampert S, et al. (2021) A conserved pathway of transdifferentiation in murine Kupffer cells. European Journal of Immunology
Li C, Wu M, Zhang H, et al. (2021) Safety, tolerability, and pharmacokinetics of the novel hepatitis B virus capsid assembly modulator GST-HG141 in healthy Chinese subjects: a first-in-human single- and multiple-dose escalation trial. Antimicrobial Agents and Chemotherapy. AAC0122021
Li C, Xiang W, Wu M, et al. (2021) A Randomized Dose-Escalation Study on the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of a Novel Recombinant Human Albumin in Healthy Subjects. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105923
Fan R, Niu J, Ma H, et al. (2021) Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy. Alimentary Pharmacology & Therapeutics
Pang X, Huang K, Zhang Q, et al. (2021) [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncology Reports. 46
Wang YC, Wei Z, Lv X, et al. (2021) A new nairo-like virus associated with human febrile illness in China. Emerging Microbes & Infections. 1-51
See more...